Genome Canada
17
7
9
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
6%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Biomarkers to Classify Heart Failure
Role: collaborator
Biomarker Guided Discharge of Heart Failure Patients
Role: collaborator
Sub-Clinical Atrial Fibrillation Biomarker Study
Role: collaborator
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children
Role: collaborator
Integrating Pediatric Pharmacogenomic Testing Into the Canadian Health Care System
Role: collaborator
Pharmacogenomics of Drug Safety in Multiple Sclerosis
Role: collaborator
Predicting Development of SCAF in Device Patients
Role: collaborator
Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
Role: collaborator
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
Role: collaborator
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Role: collaborator
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Role: collaborator
Evaluating an Online Training Program on Shared Decision-making in Prenatal Screening
Role: collaborator
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment With Antipsychotics
Role: collaborator
Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Role: collaborator
Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Role: collaborator
SpecTRA; A Study of the Validation of Protein Biomarkers in Transient Ischemic Attack
Role: collaborator
SpecTRA; An Observational Study of the Verification of Protein Biomarkers in Transient Ischemic Attack.
Role: collaborator
All 17 trials loaded